Overview

This trial is active, not recruiting.

Condition breast cancer
Treatments questionnaire, digital imaging
Sponsor M.D. Anderson Cancer Center
Start date May 2008
End date May 2017
Trial size 300 participants
Trial identifier NCT00677430, 2004-0899, RSGPB-09-157-01-CPPB

Summary

The first objective of this study is to assess the accuracy of digital image-processing techniques to provide measurements of human breast physical dimensions. The ultimate usefulness of these techniques is to develop quantitative outcome measures of the visual appearance of breast after local treatments for breast cancer. These measures will be used to improve clinical outcomes from multimodality therapy that includes surgery and radiotherapy and form the basis for the future development of patient decision making aids. The second objective is to evaluate the relationship between patient reported body image outcomes and measurement of human breast physical dimensions for patients with breast cancer.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
Arm
A brief questionnaire packet will be completed. Photographs of the breast(s) will be taken with two different types of digital cameras (2D and 3D). The photos will be used to develop automated methods for evaluating the appearance and shape of the breasts.
questionnaire Survey
A brief questionnaire packet will be completed.
digital imaging
Photographs of the breast(s) will be taken with two different types of digital cameras (2D and 3D). The photos will be used to develop automated methods for evaluating the appearance and shape of the breasts.

Primary Outcomes

Measure
Evaluate accuracy of digital image-processing techniques used to provide the physical dimensions of human breasts.
time frame: 2 years

Eligibility Criteria

Female participants at least 21 years old.

Inclusion Criteria: 1. Female. 2. Age greater than 21 years old. 3. Candidate who has had or is planning to have breast reconstructive surgery and has at least one breast mound. 4. Willing to participate in the study and able to complete informed consent. 5. Proficient at reading and speaking English. Exclusion Criteria: 1. Women who have undergone previous bilateral mastectomy without reconstruction. 2. Women who are unable to stand unassisted for 2 minutes. 3. Diagnosis of serious mental illness (e.g., schizophrenia) or cognitive impairment.

Additional Information

Official title Multimodality Anthropometric Analysis for Quantitative Assessment of Outcomes in Breast Reconstructive Surgery
Principal investigator Gregory P. Reece, MD
Description If you agree to take part in this study, you will be asked to fill out a brief questionnaire packet. This packet contains questions about how you feel about your appearance and your overall well-being. You will be asked to have photographs of your breast(s) taken with two different types of digital cameras (2D and 3D). These are the same type of photographs routinely taken for all patients having breast reconstructive surgery. The photographs and measurements will be taken during your routine clinic visit. You will not be identifiable in the photographs. The photographs will be used to develop automated methods for evaluating the appearance and shape of the breasts. You may be asked to complete additional follow-up visits for this study. These visits would take place at a regularly-scheduled clinic visit that takes place just before a surgical procedure is planned. At these visits you would be asked to fill out another questionnaire packet and to allow the research the research staff to repeat the photographs. The number of follow-up visits needed would depend on your individual treatment plan. A final study visit would take place once you feel you are finished with your breast reconstructive process. At this point, your participation in the study would be completed. Breast reconstruction is different for each patient. The length of time of the reconstructive process depends on the procedure(s) that you and your surgeon have agreed upon. These options will be discussed at your regularly scheduled clinic appointments. This is an investigational study. A total of up to 300 patients will take part in this study. All will be enrolled at UTMDACC.
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by M.D. Anderson Cancer Center.